Filing Details
- Accession Number:
- 0001213900-23-065297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-10 09:03:21
- Reporting Period:
- 2023-08-09
- Accepted Time:
- 2023-08-10 09:03:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1865494 | Io Biotech Inc. | IOBT | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1728970 | Vivo Opportunity, Llc | C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No | |
1750117 | Vivo Capital Fund Ix, L.p. | C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No | |
1750698 | Vivo Capital Ix, Llc | C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No | |
1930214 | Vivo Opportunity Fund Holdings, L.p. | C/O Vivo Capital Llc 192 Lytton Avenue Palo Alto CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-09 | 3,157,894 | $1.90 | 3,157,894 | No | 4 | P | Indirect | By Vivo Opportunity Fund Holdings, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Vivo Opportunity Fund Holdings, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (Right to Buy) | Acquisiton | 2023-08-09 | 3,157,894 | $0.13 | 3,157,894 | $2.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,157,894 | 2023-08-09 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,015,545 | Indirect | By: Vivo Capital Fund IX, L.P. |
Footnotes
- Purchase was made pursuant to that certain Securities Purchase Agreement dated as of August 7, 2023, by and among the Issuer and the purchasers named therein.
- The securities are held directly by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As the managing members of Vivo Opportunity, LLC, Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P., but each disclaims beneficial ownership of such securities except to the extent of their individual pecuniary interest therein.
- These warrants expire at 5:00 p.m. on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023, provided that the holder will be prohibited from exercising these warrants if, after giving effect to such exercise, the holder (together with such holder's affiliates and any other persons acting as a group together) would beneficially own in excess of 9.99% of the shares of common stock of the Issuer outstanding immediately after giving effect to such exercise.